Skip to main content
Top
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA)

Authors: Alcina F Nicol, Andréa Rodrigues Cordovil Pires, Simone R de Souza, Gerard J Nuovo, Beatriz Grinsztejn, Aparecida Tristão, Fabio B Russomano, Luciane Velasque, José R Lapa e Silva, Claude Pirmez

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

The oncoproteins of human papillomavirus (HPVs) directly effect cell-cycle control. We hypothesize that regulatory and cell cycle protein expression might be additionally modified in the cervix of HIV/HPV co-infected women.

Methods

We analyzed the expression of Rb, p27, VEGF and Elf-1 transcriptor factor by immunohistochemistry in 163 paraffin-embeded cervical samples using Tissue Micro-Array (TMA) and correlated this to HIV-1 and HPV infection.

Results

HIV/HPV co-infection was associated with a significant increase in expression (p < 0.001) of VEGF and p27 in both low and high grade CIN when compared to the cervices of women infected by HPV alone. Decreased Rb expression was evident with increased CIN grade in the cervices of women infected with HPV alone (p = 0.003 average of cells/mm2 in CIN I: 17.9, CIN II/III: 4.8, and tumor 3.9). Rb expression increased 3-fold for both low and high grade CIN with HPV/HIV-1 co-infection compared to HPV infection alone but did not reach statistical significance. There was a significant increase in Elf-1 expression in HPV+/HIV- women with CIN II/III and tumor (average of cells/mm2 in CIN I: 63.8; CIN II/III: 115.7 and tumor: 112.0, p = 0.005), in comparison to controls.

Conclusion

Co-infection of HPV and HIV leads to significant increase in the VEGF and p27 expression when compared to HPV+/HIV-negative infection that could facilitate viral persistence and invasive tumor development.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tjalma W, van Waes T, van den Eeden L, Bogers J: Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best practice & Research Clin Obst Gynaecol. 2005, 19 (4): 469-483. 10.1016/j.bpobgyn.2005.02.002.CrossRef Tjalma W, van Waes T, van den Eeden L, Bogers J: Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best practice & Research Clin Obst Gynaecol. 2005, 19 (4): 469-483. 10.1016/j.bpobgyn.2005.02.002.CrossRef
2.
go back to reference Cho HN, Kim TY, Kim JW: Alteration of cell cycle in cervical tumor associated with Human Papillomavirus – Cyclin-Dependent kinase inhibitors. Yonsei Med J. 2002, 43 (6): 722-728.CrossRefPubMed Cho HN, Kim TY, Kim JW: Alteration of cell cycle in cervical tumor associated with Human Papillomavirus – Cyclin-Dependent kinase inhibitors. Yonsei Med J. 2002, 43 (6): 722-728.CrossRefPubMed
3.
go back to reference Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G: Inflammation and cancer: how hot is the link?. Biochem Pharmacol. 2006, 72 (11): 1605-21. 10.1016/j.bcp.2006.06.029.CrossRefPubMed Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G: Inflammation and cancer: how hot is the link?. Biochem Pharmacol. 2006, 72 (11): 1605-21. 10.1016/j.bcp.2006.06.029.CrossRefPubMed
4.
go back to reference Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, Paba P, Costa S, Bonifacio D, Di Bonito P, Accardi L, Favalli C, Syrjanen K: Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol. 2006, 59 (1): 40-7. 10.1136/jcp.2005.026922.CrossRefPubMedPubMedCentral Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, Paba P, Costa S, Bonifacio D, Di Bonito P, Accardi L, Favalli C, Syrjanen K: Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol. 2006, 59 (1): 40-7. 10.1136/jcp.2005.026922.CrossRefPubMedPubMedCentral
5.
go back to reference Huang X, Brown C, Ni W, Maynard E, Rigby AC, Oetthen P: Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood. 2006, 107 (8): 3153-3160. 10.1182/blood-2005-08-3206.CrossRefPubMedPubMedCentral Huang X, Brown C, Ni W, Maynard E, Rigby AC, Oetthen P: Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood. 2006, 107 (8): 3153-3160. 10.1182/blood-2005-08-3206.CrossRefPubMedPubMedCentral
6.
go back to reference Troncone G, Vetrani A, de Rosa G, Palombini L: Cyclin dependent kinase inhibitor p27 expression in normal and neoplastic cervical epithelium. J Clin Pathol. 1999, 52: 880-887.CrossRefPubMedPubMedCentral Troncone G, Vetrani A, de Rosa G, Palombini L: Cyclin dependent kinase inhibitor p27 expression in normal and neoplastic cervical epithelium. J Clin Pathol. 1999, 52: 880-887.CrossRefPubMedPubMedCentral
7.
go back to reference Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, Mariani L, Sperduti I, Canalini P, Donnorso RP, Vocaturo A: Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol. 2006, 19 (3): 384-91. 10.1038/modpathol.3800551.CrossRefPubMed Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, Mariani L, Sperduti I, Canalini P, Donnorso RP, Vocaturo A: Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol. 2006, 19 (3): 384-91. 10.1038/modpathol.3800551.CrossRefPubMed
9.
go back to reference Nicol AF, Fernandes AT, Grinsztejn B, Russomano F, E Silva JR, Tristao A, Perez M, Nuovo GJ, Martinez-Maza O, Bonecini-Almeida M: Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol. 2005, 14 (1): 39-47. 10.1097/01.pas.0000143309.81183.6c.CrossRefPubMed Nicol AF, Fernandes AT, Grinsztejn B, Russomano F, E Silva JR, Tristao A, Perez M, Nuovo GJ, Martinez-Maza O, Bonecini-Almeida M: Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol. 2005, 14 (1): 39-47. 10.1097/01.pas.0000143309.81183.6c.CrossRefPubMed
10.
go back to reference Nicol AF, Nuovo GJ, Salomão-Estevez A, Grinsztein B, Tristão A, Russomano F, Lapa E Silva JR, Oliveira MP, Pirmez C: Immune factors involved in the cervical immune response in the HIV/HPV co-infection. J Clin Pathol. 2008, 61 (1): 84-8. 10.1136/jcp.2007.047290.CrossRefPubMed Nicol AF, Nuovo GJ, Salomão-Estevez A, Grinsztein B, Tristão A, Russomano F, Lapa E Silva JR, Oliveira MP, Pirmez C: Immune factors involved in the cervical immune response in the HIV/HPV co-infection. J Clin Pathol. 2008, 61 (1): 84-8. 10.1136/jcp.2007.047290.CrossRefPubMed
11.
go back to reference Gage JR, Sandhu AK, Nihira M, Bonecini-Almeida M da G, Cristoforoni P, Kishimoto T, Montz FJ, Martínez-Maza O: Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression. Obstet Gynecol. 2000, 96 (6): 879-85. 10.1016/S0029-7844(00)01057-7.PubMed Gage JR, Sandhu AK, Nihira M, Bonecini-Almeida M da G, Cristoforoni P, Kishimoto T, Montz FJ, Martínez-Maza O: Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression. Obstet Gynecol. 2000, 96 (6): 879-85. 10.1016/S0029-7844(00)01057-7.PubMed
12.
go back to reference Nyagol J, Leucci E, Onnis A, De Falco G, Tigli C, Sanseverino F, Torriccelli M, Palummo N, Pacenti L, Santopietro R, Spina D, Gichangi P, Muchiri L, Lazzi S, Petraglia F, Leoncini L, Giordano A: The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther. 2006, 5 (6): 684-90.CrossRefPubMed Nyagol J, Leucci E, Onnis A, De Falco G, Tigli C, Sanseverino F, Torriccelli M, Palummo N, Pacenti L, Santopietro R, Spina D, Gichangi P, Muchiri L, Lazzi S, Petraglia F, Leoncini L, Giordano A: The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther. 2006, 5 (6): 684-90.CrossRefPubMed
13.
go back to reference Pires AR, da Matta Andreiuolo F, de Souza SR: TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles. Diagn Pathol. 2006, 25 (1): 14-10.1186/1746-1596-1-14.CrossRef Pires AR, da Matta Andreiuolo F, de Souza SR: TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles. Diagn Pathol. 2006, 25 (1): 14-10.1186/1746-1596-1-14.CrossRef
14.
go back to reference Nicol AF, Nuovo GJ, RT in situ PCR: Protocols and Applications in Methods in Microbiology. Edited by: Tor Savidge, Charalabos P. 2005, Elsevier Acad Press, 34: 239-254. Nicol AF, Nuovo GJ, RT in situ PCR: Protocols and Applications in Methods in Microbiology. Edited by: Tor Savidge, Charalabos P. 2005, Elsevier Acad Press, 34: 239-254.
15.
go back to reference Nicol AF, Nuovo GJ, Wang Y, Grinsztejn B, Tristao A, Russomano F, Perez MA, Lapa e Silva JR, Fernandes AT, Gage JR, Martinez-Maza O, Bonecini-Almeida MG: In situ detection of SOCS and cytokine expression in the uterine cervix from HIV/HPV coinfected women. Exp Mol Pathol. 2006, 81 (1): 42-7. 10.1016/j.yexmp.2006.01.002.CrossRefPubMed Nicol AF, Nuovo GJ, Wang Y, Grinsztejn B, Tristao A, Russomano F, Perez MA, Lapa e Silva JR, Fernandes AT, Gage JR, Martinez-Maza O, Bonecini-Almeida MG: In situ detection of SOCS and cytokine expression in the uterine cervix from HIV/HPV coinfected women. Exp Mol Pathol. 2006, 81 (1): 42-7. 10.1016/j.yexmp.2006.01.002.CrossRefPubMed
16.
go back to reference Moberg M, Gustavsson I, Gyllensten U: Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer. 2004, 112: 854-859. 10.1002/ijc.20480.CrossRefPubMed Moberg M, Gustavsson I, Gyllensten U: Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer. 2004, 112: 854-859. 10.1002/ijc.20480.CrossRefPubMed
17.
go back to reference Tjalma WA, Arbyan M, Paavonen J, van Waes TR, Bogers JJ: Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. Int J Gynecol Cancer. 2004, 14: 751-761. 10.1111/j.1048-891X.2004.014505.x.CrossRefPubMed Tjalma WA, Arbyan M, Paavonen J, van Waes TR, Bogers JJ: Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. Int J Gynecol Cancer. 2004, 14: 751-761. 10.1111/j.1048-891X.2004.014505.x.CrossRefPubMed
18.
go back to reference Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol. 1996, 70 (6): 4053-62.PubMedPubMedCentral Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol. 1996, 70 (6): 4053-62.PubMedPubMedCentral
19.
go back to reference Goff BA, Sallin J, Garcia R, VanBlaricom A, Paley PJ, Muntz HG: Evaluation of p27 in preinvasive and invasive malignancies of the cervix. Gynecol Oncol. 2003, 88 (1): 40-4. 10.1006/gyno.2002.6858.CrossRefPubMed Goff BA, Sallin J, Garcia R, VanBlaricom A, Paley PJ, Muntz HG: Evaluation of p27 in preinvasive and invasive malignancies of the cervix. Gynecol Oncol. 2003, 88 (1): 40-4. 10.1006/gyno.2002.6858.CrossRefPubMed
20.
go back to reference Shiozawa T, Shiohara S, Kanai M, Konishi I, Fujii S, Nikaido T: Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1). Cancer. 2001, 92 (12): 3005-11. 10.1002/1097-0142(20011215)92:12<3005::AID-CNCR10153>3.0.CO;2-6.CrossRefPubMed Shiozawa T, Shiohara S, Kanai M, Konishi I, Fujii S, Nikaido T: Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1). Cancer. 2001, 92 (12): 3005-11. 10.1002/1097-0142(20011215)92:12<3005::AID-CNCR10153>3.0.CO;2-6.CrossRefPubMed
21.
go back to reference Clarke B, Chetty R: Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2001, 82 (2): 238-46. 10.1006/gyno.2001.6306.CrossRefPubMed Clarke B, Chetty R: Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2001, 82 (2): 238-46. 10.1006/gyno.2001.6306.CrossRefPubMed
22.
go back to reference Nam EJ, Kim JW, Kim SW, Kim YT, Kim JH, Yoon BS, Cho NH, Kim S: The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance. Gynecol Oncol. 2007, 104 (1): 207-11. 10.1016/j.ygyno.2006.07.043.CrossRefPubMed Nam EJ, Kim JW, Kim SW, Kim YT, Kim JH, Yoon BS, Cho NH, Kim S: The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance. Gynecol Oncol. 2007, 104 (1): 207-11. 10.1016/j.ygyno.2006.07.043.CrossRefPubMed
23.
go back to reference Tringler B, Gup CJ, Singh M, Groshong S, Shroyer AL, Heinz DA, Shroyer KR: Evaluation of p16INK4A and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol. 2004, 35 (6): 689-696. 10.1016/j.humpath.2004.02.012.CrossRefPubMed Tringler B, Gup CJ, Singh M, Groshong S, Shroyer AL, Heinz DA, Shroyer KR: Evaluation of p16INK4A and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol. 2004, 35 (6): 689-696. 10.1016/j.humpath.2004.02.012.CrossRefPubMed
24.
go back to reference Stiegler P, Kasten M, Giordano A: The RB family of cell cycle regulatory factors. J Cell Biochem Suppl. 1998, 31: 30-6. 10.1002/(SICI)1097-4644(1998)72:30/31+<30::AID-JCB5>3.0.CO;2-J. ReviewCrossRef Stiegler P, Kasten M, Giordano A: The RB family of cell cycle regulatory factors. J Cell Biochem Suppl. 1998, 31: 30-6. 10.1002/(SICI)1097-4644(1998)72:30/31+<30::AID-JCB5>3.0.CO;2-J. ReviewCrossRef
25.
go back to reference De Falco G, Bellan C, Lazzi S, Claudio P, La Sala D, Cinti C, Tosi P, Giordano A, Leoncini L: Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene. 2003, 22 (40): 6214-9. 10.1038/sj.onc.1206637.CrossRefPubMed De Falco G, Bellan C, Lazzi S, Claudio P, La Sala D, Cinti C, Tosi P, Giordano A, Leoncini L: Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene. 2003, 22 (40): 6214-9. 10.1038/sj.onc.1206637.CrossRefPubMed
Metadata
Title
Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA)
Authors
Alcina F Nicol
Andréa Rodrigues Cordovil Pires
Simone R de Souza
Gerard J Nuovo
Beatriz Grinsztejn
Aparecida Tristão
Fabio B Russomano
Luciane Velasque
José R Lapa e Silva
Claude Pirmez
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-289

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine